Literature DB >> 15576945

The Ipl1/Aurora kinase family: methods of inhibition and functional analysis in mammalian cells.

Claire Ditchfield1, Nicholas Keen, Stephen S Taylor.   

Abstract

The Ipl1/Aurora family of protein kinases are required for accurate chromosome segregation. Because members of this family are often overexpressed in human tumors, they have recently received much attention, both from the academic community and the pharmaceutical industry. Indeed, two small molecule Aurora kinase inhibitors have recently been described. In this chapter, we describe several methods for investigating the function of the Aurora kinases, focusing on Aurora B. We describe the use of the small-molecule inhibitor ZM447439, RNA interference, and overexpression of a catalytic mutant. All of these methods have proved useful in studying Aurora B as well as validating it as a potential anticancer drug target. However, while all three methods are useful for probing the function of Aurora B, each has inherent advantages and disadvantages. Furthermore, because the mechanism underlying the inhibition is different in each case, caution must be taken when interpreting the data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15576945     DOI: 10.1385/1-59259-857-9:371

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  An alternative splicing network links cell-cycle control to apoptosis.

Authors:  Michael J Moore; Qingqing Wang; Caleb J Kennedy; Pamela A Silver
Journal:  Cell       Date:  2010-08-12       Impact factor: 41.582

2.  Benzo[e]pyridoindoles, novel inhibitors of the aurora kinases.

Authors:  Thi My-Nhung Hoang; Bertrand Favier; Annie Valette; Caroline Barette; Chi Hung Nguyen; Laurence Lafanechère; David S Grierson; Stéfan Dimitrov; Annie Molla
Journal:  Cell Cycle       Date:  2009-03-18       Impact factor: 4.534

3.  Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation.

Authors:  Rebecca J Loomis; Yoshinori Naoe; J Brandon Parker; Velibor Savic; Matthew R Bozovsky; Todd Macfarlan; James L Manley; Debabrata Chakravarti
Journal:  Mol Cell       Date:  2009-02-27       Impact factor: 17.970

4.  A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors.

Authors:  P Gollapudi; L S Hasegawa; D A Eastmond
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2014-03-26       Impact factor: 2.873

5.  CtBPs promote cell survival through the maintenance of mitotic fidelity.

Authors:  Lee M Bergman; Charles N Birts; Matthew Darley; Brian Gabrielli; Jeremy P Blaydes
Journal:  Mol Cell Biol       Date:  2009-06-08       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.